-
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Recommendation of "Buy" from Analysts
Source: Buzz FX / 07 Jan 2025 01:23:15 America/Chicago
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Recommendation of "Buy" from Analysts Written by MarketBeat January 7, 2025 Share Link copied to clipboard. Shares of Larimar Therapeutics, Inc.
Read more...